Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company. The company focuses on the research, development, manufacturing, and commercialization of human vaccines and related products with focus on disease prevention and control. Its product portfolio includes vaccines for COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps. Sinovac Biotech's vaccines are used in the healthcare industry for disease prevention and control. While the company primarily operates in China, it also supplies vaccines to other countries in Asia, Africa, the Mediterranean region, and Central America. Sinovac Biotech is headquartered in Beijing, China.

Gain a 360-degree view of Sinovac Biotech Ltd and make more informed decisions for your business Gain a 360-degree view of Sinovac Biotech Ltd and make more informed decisions for your business Register your interest
Headquarters China

Address No. 39 Shangdi West Road, Beijing, 100085


Telephone 86 10 82799800

No of Employees 3,037

Industry Pharmaceuticals and Healthcare

Revenue (2023) $448.3M

   

   

Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Sinovac Biotech Ltd premium industry data and analytics

120+

Clinical Trials

Determine Sinovac Biotech Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Sinovac Biotech Ltd’s relevant decision makers and contact details.

50+

Catalyst Calendar

Proactively evaluate Sinovac Biotech Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

20+

Pipeline Drugs

Identify which of Sinovac Biotech Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

13+

Marketed Drugs

Understand Sinovac Biotech Ltd’s commercialized product portfolio to stay one step ahead of the market.

10+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

9

Sales & Consensus Forecasts

Understand the current and future drug revenue for Sinovac Biotech Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

1

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products Services Brands
Hepatitis A and B Vaccine Distribution Services CoronaVac
H1N1 Influenza A Vaccine Healive
Mumps Vaccine Anflu
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Sinovac Biotech Ltd portfolio and identify potential areas for collaboration Understand Sinovac Biotech Ltd portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 Regulatory Approval In January, the company received approval from the Macao Food and Drug Administration for varicella live attenuated vaccine.
2024 Acquisitions/Mergers/Takeovers In December, the company announced the acquisition of Sinovac (Chengdu) Biological Products Co Ltd, a biopharmaceutical company that focuses on the research and development and production of innovative vaccines.
2024 Contracts/Agreements In August, the company entered into an agreement with Yunnan Provincial Center for Disease Control and Prevention to jointly promote cooperation at a higher level and in a wider range of fields.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters Sinovac Biotech Ltd Hualan Biological Engineering Inc Walvax Biotechnology Co Ltd Changchun Bcht Biotechnology Co Ltd Changchun Keygen Biological Products Co Ltd
Headquarters China China China China China
City Beijing Xinxiang Kunming Changchun Changchun
State/Province Beijing Henan Yunnan Jilin Jilin
No. of Employees 3,037 4,117 1,981 1,274 -
Entity Type Private Public Public Public Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Weidong Yin Chief Executive Officer; Director Executive Board 2003 60
Yumin Qiu Director Non Executive Board - -
Yuk Lam Lo Director Non Executive Board 2006 74
Yu Wang Director Non Executive Board - -
Simon Anderson Director Non Executive Board 2004 63
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Sinovac Biotech Ltd key executives to enhance your sales strategy Gain insight into Sinovac Biotech Ltd key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?